<DOC>
	<DOCNO>NCT02388087</DOCNO>
	<brief_summary>The purpose study investigate efficacy ROX coupler treat patient tilt test proven Neurally mediate syncope .</brief_summary>
	<brief_title>The Iliac Arterio-venous Fistula Treatment Neurally Mediated Syncope Study</brief_title>
	<detailed_description>Neurally mediate syncope ( NMS ) debilitate condition , proven therapeutic measure . The ROX coupler device use create Iliac arterio-venous anastamosis allow shunt 0.8 litre per minute . The haemodynamic change follow creation arterio-venous anastomosis iliac level lead increase cardiac preload , reverse find thought induce NMS . This randomise control study evaluate effect Iliac arterio-venous anastamosis patient neurally mediate syncope . The Head tilt test use objective measure evaluate effect arterio-venous anastamosis patient NMS . Participants tilt test proven NMS eligible study ( satisfy eligibility criterion ) . Participants randomise ROX coupler intervention standard therapy . The primary outcome measure absence loss consciousness tilt table test 3 month post intervention .</detailed_description>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Syncope</mesh_term>
	<mesh_term>Arteriovenous Fistula</mesh_term>
	<criteria>Absence transient loss consciousness associate reflex bradycardia hypotension tilt test 3 month follow randomise intervention Time first episode syncope randomise intervention Number syncopal episode first 3 month randomise intervention . Tilt table response 6 month follow randomise intervention i.e . 3 month unblinding Number syncopal episode 6 month intervention i.e . 3 month unblinding</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>